New startup Aglaia Therapeutics raises €4M in seed funding to overcome resistance in oncology targeted therapies
Venture capital firm Advent France Biotechnology led fundraising, alongside Crédit Mutuel Innovation and Pierre Fabre Co-founded by AFB and leading cancer institutes Gustave Roussy and Institut Curie, startup will use funding to prepare essential preclinical work to identify first oncology program to develop Villejuif, France, September 27, 2021 – Aglaia Therapeutics, a biotechnology startup developing promising new therapies that […]